Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2022 Jan 4;5(1):e2136921.
doi: 10.1001/jamanetworkopen.2021.36921.

Comparison of Prolonged Exposure vs Cognitive Processing Therapy for Treatment of Posttraumatic Stress Disorder Among US Veterans: A Randomized Clinical Trial

Paula P Schnurr  1   2 , Kathleen M Chard  3   4 , Josef I Ruzek  5   6   7 , Bruce K Chow  8 , Patricia A Resick  9 , Edna B Foa  10 , Brian P Marx  11   12   13 , Matthew J Friedman  1   2 , Michelle J Bovin  11   12   13 , Kristina L Caudle  1 , Diane Castillo  14 , Kyle T Curry  15 , Michael Hollifield  16   17   18 , Grant D Huang  19 , Christine L Chee  20 , Millie C Astin  21 , Benjamin Dickstein  3 , Kerry Renner  22 , Carolina P Clancy  23 , Claire Collie  23 , Kelly Maieritsch  24 , Su Bailey  25   26 , Karin Thompson  25   26 , Michael Messina  27   28 , Laurel Franklin  29   30 , Steve Lindley  31   32 , Karen Kattar  33 , Brandi Luedtke  33 , Jennifer Romesser  34 , John McQuaid  35   36 , Patrick Sylvers  37   38 , Ruth Varkovitzky  37   38 , Lori Davis  39   40 , David MacVicar  39   40 , Mei-Chiung Shih  5   8
Affiliations
Comparative Study

Comparison of Prolonged Exposure vs Cognitive Processing Therapy for Treatment of Posttraumatic Stress Disorder Among US Veterans: A Randomized Clinical Trial

Paula P Schnurr et al. JAMA Netw Open. .

Abstract

Importance: Posttraumatic stress disorder (PTSD) is a prevalent and serious mental health problem. Although there are effective psychotherapies for PTSD, there is little information about their comparative effectiveness.

Objective: To compare the effectiveness of prolonged exposure (PE) vs cognitive processing therapy (CPT) for treating PTSD in veterans.

Design, setting, and participants: This randomized clinical trial assessed the comparative effectiveness of PE vs CPT among veterans with military-related PTSD recruited from outpatient mental health clinics at 17 Department of Veterans Affairs medical centers across the US from October 31, 2014, to February 1, 2018, with follow-up through February 1, 2019. The primary outcome was assessed using centralized masking. Tested hypotheses were prespecified before trial initiation. Data were analyzed from October 5, 2020, to May 5, 2021.

Interventions: Participants were randomized to 1 of 2 individual cognitive-behavioral therapies, PE or CPT, delivered according to a flexible protocol of 10 to 14 sessions.

Main outcomes and measures: The primary outcome was change in PTSD symptom severity on the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) from before treatment to the mean after treatment across posttreatment and 3- and 6-month follow-ups. Secondary outcomes included other symptoms, functioning, and quality of life.

Results: Analyses were based on all 916 randomized participants (730 [79.7%] men and 186 [20.3%] women; mean [range] age 45.2 [21-80] years), with 455 participants randomized to PE (mean CAPS-5 score at baseline, 39.9 [95% CI, 39.1-40.7] points) and 461 participants randomized to CPT (mean CAPS-5 score at baseline, 40.3 [95% CI, 39.5-41.1] points). PTSD severity on the CAPS-5 improved substantially in both PE (standardized mean difference [SMD], 0.99 [95% CI, 0.89-1.08]) and CPT (SMD, 0.71 [95% CI, 0.61-0.80]) groups from before to after treatment. Mean improvement was greater in PE than CPT (least square mean, 2.42 [95% CI, 0.53-4.31]; P = .01), but the difference was not clinically significant (SMD, 0.17). Results for self-reported PTSD symptoms were comparable with CAPS-5 findings. The PE group had higher odds of response (odds ratio [OR], 1.32 [95% CI, 1.00-1.65]; P < .001), loss of diagnosis (OR, 1.43 [95% CI, 1.12-1.74]; P < .001), and remission (OR, 1.62 [95% CI, 1.24-2.00]; P < .001) compared with the CPT group. Groups did not differ on other outcomes. Treatment dropout was higher in PE (254 participants [55.8%]) than in CPT (215 participants [46.6%]; P < .01). Three participants in the PE group and 1 participant in the CPT group were withdrawn from treatment, and 3 participants in each treatment dropped out owing to serious adverse events.

Conclusions and relevance: This randomized clinical trial found that although PE was statistically more effective than CPT, the difference was not clinically significant, and improvements in PTSD were meaningful in both treatment groups. These findings highlight the importance of shared decision-making to help patients understand the evidence and select their preferred treatment.

Trial registration: ClinicalTrials.gov Identifier: NCT01928732.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Schnurr reported receiving grants from the Department of Veterans Affairs (VA), Department of Defense (DoD), National Institute of Mental Health (NIMH), and Patient-Centered Outcomes Research Institute (PCORI) outside the submitted work. Dr Chard reported grants receiving from Cincinnati VA Medical Center Chris T. Sullivan Foundation, DoD, and royalties from Guilford Publications. Dr Ruzek reported receiving personal fees from the National Institute for Human Resilience, Canadian Red Cross, Institute of Psychology at the Chinese Academy of Sciences, and University of Washington. Dr Resick reported receiving grants from NIMH, personal fees from DoD Office of Victims of Crime at the Medical University of South Carolina, and royalties from Guilford. Dr Foa reported receiving personal fees from PTSD workshops and royalties from Oxford University Press outside the submitted work. Dr Marx reported receiving grants from the VA, PCORI, NIMH, Military Suicide Research Consortium, and DoD and personal fees from American Psychological Association outside the submitted work. Dr Bovin reported receiving grants from the VA and personal fees from Premier Research outside the submitted work. Dr Astin reported grants from Collective Studies Program paid for study coordinator and supplies only during the conduct of the study. Dr Collie reported serving on the Advisory Steering Committee for the American Psychological Association’s Clinical Practice Guidelines. Dr Franklin reported receiving personal fees from New Harbinger Publications Royalties and grants from Patient-Centered Outcomes Research Institute outside the submitted work. Dr Davis reported receiving personal fees from Otsuka, Lundbeck, Janssen, and Signant Health and grants from Tonix, Alkermes, Allergan, Aptinyx, VA, DoD, Substance Abuse and Mental Health Services Administration, Social Finance, and Westat. No other disclosures were reported.

Figures

Figure.
Figure.. Participant Recruitment Flowchart
aParticipants may have multiple reasons for exclusion. bOne ineligible patient was randomized and met the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) cutoff score but did not meet on Criterion E. One patient who was randomized to cognitive processing therapy (CPT) inadvertently received prolong exposure (PE), and 1 patient who was randomized to PE received CPT owing to staff error. cCompletion according to study protocol could be between 10 and 14 sessions; the number of sessions could be flexed according to patient need.
See this image and copyright information in PMC

References

    1. Karlin BE, Cross G. From the laboratory to the therapy room: national dissemination and implementation of evidence-based psychotherapies in the U.S. Department of Veterans Affairs Health Care System. Am Psychol. 2014;69(1):19-33. doi:10.1037/a0033888 - DOI - PubMed
    1. Hamblen JL, Norman SB, Sonis JH, et al. . A guide to guidelines for the treatment of posttraumatic stress disorder in adults: an update. Psychotherapy (Chic). 2019;56(3):359-373. doi:10.1037/pst0000231 - DOI - PubMed
    1. The Management of Posttraumatic Stress Disorder Work Group . VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder, Version 3.0. Department of Veterans Affairs and Department of Defense; 2017.
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013.
    1. Goldstein RB, Smith SM, Chou SP, et al. . The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Soc Psychiatry Psychiatr Epidemiol. 2016;51(8):1137-1148. doi:10.1007/s00127-016-1208-5 - DOI - PMC - PubMed

Publication types

Associated data